HIPPO HOLDINGS INC (HIPO) Fundamental Analysis & Valuation

NYSE:HIPO • US4335392027

Current stock price

25.58 USD
-0.07 (-0.27%)
At close:
25.58 USD
0 (0%)
After Hours:

This HIPO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. HIPO Profitability Analysis

1.1 Basic Checks

  • In the past year HIPO was profitable.
  • HIPO had a negative operating cash flow in the past year.
  • In the past 5 years HIPO reported 4 times negative net income.
  • In multiple years HIPO reported negative operating cash flow during the last 5 years.
HIPO Yearly Net Income VS EBIT VS OCF VS FCFHIPO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M -300M

1.2 Ratios

  • With a decent Return On Assets value of 5.12%, HIPO is doing good in the industry, outperforming 78.38% of the companies in the same industry.
  • With an excellent Return On Equity value of 22.75%, HIPO belongs to the best of the industry, outperforming 89.19% of the companies in the same industry.
Industry RankSector Rank
ROA 5.12%
ROE 22.75%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HIPO Yearly ROA, ROE, ROICHIPO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80

1.3 Margins

  • With an excellent Profit Margin value of 21.31%, HIPO belongs to the best of the industry, outperforming 87.16% of the companies in the same industry.
  • The Operating Margin and Gross Margin are not available for HIPO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 21.31%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HIPO Yearly Profit, Operating, Gross MarginsHIPO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. HIPO Health Analysis

2.1 Basic Checks

  • HIPO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • HIPO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
HIPO Yearly Shares OutstandingHIPO Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
HIPO Yearly Total Debt VS Total AssetsHIPO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • Based on the Altman-Z score of -0.40, we must say that HIPO is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of HIPO (-0.40) is better than 66.22% of its industry peers.
  • A Debt/Equity ratio of 0.11 indicates that HIPO is not too dependend on debt financing.
  • HIPO has a Debt to Equity ratio of 0.11. This is in the better half of the industry: HIPO outperforms 75.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z -0.4
ROIC/WACCN/A
WACC9.03%
HIPO Yearly LT Debt VS Equity VS FCFHIPO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 3.79 indicates that HIPO has no problem at all paying its short term obligations.
  • HIPO has a better Current ratio (3.79) than 94.59% of its industry peers.
  • A Quick Ratio of 3.79 indicates that HIPO has no problem at all paying its short term obligations.
  • HIPO's Quick ratio of 3.79 is amongst the best of the industry. HIPO outperforms 94.59% of its industry peers.
Industry RankSector Rank
Current Ratio 3.79
Quick Ratio 3.79
HIPO Yearly Current Assets VS Current LiabilitesHIPO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. HIPO Growth Analysis

3.1 Past

  • HIPO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 203.38%, which is quite impressive.
  • Looking at the last year, HIPO shows a very strong growth in Revenue. The Revenue has grown by 25.93%.
  • The Revenue has been growing by 55.46% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)203.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-86.55%
Revenue 1Y (TTM)25.93%
Revenue growth 3Y57.6%
Revenue growth 5Y55.46%
Sales Q2Q%18.04%

3.2 Future

  • The Earnings Per Share is expected to grow by 16.30% on average over the next years. This is quite good.
  • HIPO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.06% yearly.
EPS Next Y-95.39%
EPS Next 2Y-36.22%
EPS Next 3Y16.3%
EPS Next 5YN/A
Revenue Next Year24.38%
Revenue Next 2Y23.81%
Revenue Next 3Y22.06%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
HIPO Yearly Revenue VS EstimatesHIPO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
HIPO Yearly EPS VS EstimatesHIPO Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 -5 -10

More info and screens

Find the best growth stocksShow best growing peers

2

4. HIPO Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 11.95, the valuation of HIPO can be described as reasonable.
  • HIPO's Price/Earnings ratio is in line with the industry average.
  • When comparing the Price/Earnings ratio of HIPO to the average of the S&P500 Index (25.23), we can say HIPO is valued rather cheaply.
  • The Price/Forward Earnings ratio is 259.42, which means the current valuation is very expensive for HIPO.
  • Based on the Price/Forward Earnings ratio, HIPO is valued expensively inside the industry as 82.43% of the companies are valued cheaper.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.28, HIPO is valued quite expensively.
Industry RankSector Rank
PE 11.95
Fwd PE 259.42
HIPO Price Earnings VS Forward Price EarningsHIPO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HIPO Per share dataHIPO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • A more expensive valuation may be justified as HIPO's earnings are expected to grow with 16.30% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-36.22%
EPS Next 3Y16.3%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HIPO Dividend Analysis

5.1 Amount

  • HIPO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HIPO Fundamentals: All Metrics, Ratios and Statistics

HIPPO HOLDINGS INC

NYSE:HIPO (3/20/2026, 8:04:00 PM)

After market: 25.58 0 (0%)

25.58

-0.07 (-0.27%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)02-25
Earnings (Next)05-05
Inst Owners53.58%
Inst Owner Change8.11%
Ins Owners10.23%
Ins Owner Change1.99%
Market Cap664.31M
Revenue(TTM)468.60M
Net Income(TTM)95.90M
Analysts80
Price Target40.46 (58.17%)
Short Float %2.88%
Short Ratio4.37
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)98.4%
Min EPS beat(2)89.54%
Max EPS beat(2)107.26%
EPS beat(4)3
Avg EPS beat(4)215.38%
Min EPS beat(4)-18.4%
Max EPS beat(4)683.12%
EPS beat(8)6
Avg EPS beat(8)113.05%
EPS beat(12)7
Avg EPS beat(12)69.89%
EPS beat(16)7
Avg EPS beat(16)40.05%
Revenue beat(2)1
Avg Revenue beat(2)0.27%
Min Revenue beat(2)-0.53%
Max Revenue beat(2)1.08%
Revenue beat(4)3
Avg Revenue beat(4)0.99%
Min Revenue beat(4)-0.53%
Max Revenue beat(4)2.13%
Revenue beat(8)5
Avg Revenue beat(8)3.95%
Revenue beat(12)8
Avg Revenue beat(12)4.79%
Revenue beat(16)9
Avg Revenue beat(16)3.48%
PT rev (1m)0%
PT rev (3m)-1.65%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)383.35%
EPS NY rev (3m)866.7%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)5.51%
Revenue NY rev (3m)4.6%
Valuation
Industry RankSector Rank
PE 11.95
Fwd PE 259.42
P/S 1.48
P/FCF N/A
P/OCF N/A
P/B 1.58
P/tB 1.82
EV/EBITDA N/A
EPS(TTM)2.14
EY8.37%
EPS(NY)0.1
Fwd EY0.39%
FCF(TTM)-0.45
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS17.33
BVpS16.23
TBVpS14.02
PEG (NY)N/A
PEG (5Y)N/A
Graham Number27.96
Profitability
Industry RankSector Rank
ROA 5.12%
ROE 22.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 21.31%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 54.9%
Cap/Sales 2.49%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.79
Quick Ratio 3.79
Altman-Z -0.4
F-Score6
WACC9.03%
ROIC/WACCN/A
Cap/Depr(3y)117.59%
Cap/Depr(5y)128.11%
Cap/Sales(3y)9.44%
Cap/Sales(5y)12.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)203.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-86.55%
EPS Next Y-95.39%
EPS Next 2Y-36.22%
EPS Next 3Y16.3%
EPS Next 5YN/A
Revenue 1Y (TTM)25.93%
Revenue growth 3Y57.6%
Revenue growth 5Y55.46%
Sales Q2Q%18.04%
Revenue Next Year24.38%
Revenue Next 2Y23.81%
Revenue Next 3Y22.06%
Revenue Next 5YN/A
EBIT growth 1Y72.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year147.68%
EBIT Next 3Y64.73%
EBIT Next 5YN/A
FCF growth 1Y-19.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-107.41%
OCF growth 3YN/A
OCF growth 5YN/A

HIPPO HOLDINGS INC / HIPO Fundamental Analysis FAQ

What is the fundamental rating for HIPO stock?

ChartMill assigns a fundamental rating of 3 / 10 to HIPO.


What is the valuation status for HIPO stock?

ChartMill assigns a valuation rating of 2 / 10 to HIPPO HOLDINGS INC (HIPO). This can be considered as Overvalued.


Can you provide the profitability details for HIPPO HOLDINGS INC?

HIPPO HOLDINGS INC (HIPO) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for HIPO stock?

The Earnings per Share (EPS) of HIPPO HOLDINGS INC (HIPO) is expected to decline by -95.39% in the next year.